Inhibition or promotion of tumor growth by granulocyte-macrophage colony stimulating factor derived from engineered tumor cells is dose-dependent.

Abstract

BACKGROUND Granulocyte-macrophage colony stimulating factor (GM-CSF) has been widely investigated as an adjuvant factor for tumor immunotherapy. However, the results are controversial with antitumor effects in some studies and a tumor growth promotion effect in others. MATERIALS AND METHODS In order to determine whether there is a dose-dependent effect of… (More)

Topics

4 Figures and Tables

Cite this paper

@article{Li2004InhibitionOP, title={Inhibition or promotion of tumor growth by granulocyte-macrophage colony stimulating factor derived from engineered tumor cells is dose-dependent.}, author={Jinhua Li and Hilary Bouton-Verville and Lillia M. Holmes and Kelly E Burgin and Susan Jakubchak and Xianzhong Yu and Thomas E. Wagner and Yanzhang Wei}, journal={Anticancer research}, year={2004}, volume={24 5A}, pages={2717-21} }